171 related articles for article (PubMed ID: 21358410)
1. Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.
Vos J; Jansen AM; Menko F; van Asperen CJ; Stiggelbout AM; Tibben A
Genet Med; 2011 Apr; 13(4):333-41. PubMed ID: 21358410
[TBL] [Abstract][Full Text] [Related]
2. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.
Vos J; Menko F; Jansen AM; van Asperen CJ; Stiggelbout AM; Tibben A
Fam Cancer; 2011 Mar; 10(1):87-96. PubMed ID: 20852944
[TBL] [Abstract][Full Text] [Related]
3. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
4. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
[TBL] [Abstract][Full Text] [Related]
5. Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
Vos J; Oosterwijk JC; Gómez-García E; Menko FH; Jansen AM; Stoel RD; van Asperen CJ; Tibben A; Stiggelbout AM
Clin Genet; 2011 Mar; 79(3):207-18. PubMed ID: 21114486
[TBL] [Abstract][Full Text] [Related]
6. A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure.
Vos J; Stiggelbout AM; Oosterwijk J; Gomez-Garcia E; Menko F; Collee JM; van Asperen CJ; Tibben A
Genet Med; 2011 Sep; 13(9):800-11. PubMed ID: 21885922
[TBL] [Abstract][Full Text] [Related]
7. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
[TBL] [Abstract][Full Text] [Related]
8. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Hughes C; Lerman C; Schwartz M; Peshkin BN; Wenzel L; Narod S; Corio C; Tercyak KP; Hanna D; Isaacs C; Main D
Am J Med Genet; 2002 Jan; 107(2):143-50. PubMed ID: 11807889
[TBL] [Abstract][Full Text] [Related]
9. Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.
Daly MB; Montgomery S; Bingler R; Ruth K
Fam Cancer; 2016 Oct; 15(4):697-706. PubMed ID: 26897130
[TBL] [Abstract][Full Text] [Related]
10. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
[TBL] [Abstract][Full Text] [Related]
12. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
Seven M; Shah LL; Yazici H; Daack-Hirsch S
Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
[TBL] [Abstract][Full Text] [Related]
13. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
[TBL] [Abstract][Full Text] [Related]
14. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
[TBL] [Abstract][Full Text] [Related]
15. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
[TBL] [Abstract][Full Text] [Related]
16. How families communicate about HNPCC genetic testing: findings from a qualitative study.
Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
[TBL] [Abstract][Full Text] [Related]
17. Communication of genetic information to at-risk relatives during the multidisciplinary monitoring of vascular Ehlers-Danlos syndrome in a French referral clinic.
Mazzella JM; Adham S; Frank M; Legrand A; Lahlou-Laforêt K; Jeunemaitre X
J Genet Couns; 2020 Oct; 29(5):828-837. PubMed ID: 31903687
[TBL] [Abstract][Full Text] [Related]
18. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
19. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
[TBL] [Abstract][Full Text] [Related]
20. [Integrating close relatives of people experiencing schizophrenia in the mental health system].
Villani M; Kovess-Masféty V
Encephale; 2020 Jun; 46(3):177-183. PubMed ID: 31959464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
